Verastem (VSTM) Tops Q3 EPS by 3c

Verastem (NASDAQ: VSTM) reported Q3 EPS of ($0.21), $0.03 better than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Verastem (VSTM) click here.

You May Also Be Interested In

• Verastem (VSTM) PT Lowered to $13 at Mizuho
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
• Bernstein SocGen Group Reiterates Outperform Rating on JD.com, Inc (JD), 'very cheaply valued'